| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/16/2012 | US20120039813 Intrinsically colored, luminescent silk fibroin and a method of producing the same |
| 02/16/2012 | US20120039806 Compounds and Methods for Modulating an Immune Response |
| 02/16/2012 | US20120039805 Therapeutics And Methods For Treating Neoplastic Diseases Comprising Determining The Level Of Caveolin-1 And/Or Caveolin-2 In A Stromal Cell Sample |
| 02/16/2012 | US20120039802 Peptides that specifically bind hgf receptor (cmet) and uses thereof |
| 02/16/2012 | US20120039801 SPARC binding peptides and uses thereof |
| 02/16/2012 | US20120039800 Platinum Acridine Anti-Cancer Compounds And Methods Thereof |
| 02/16/2012 | US20120039798 Methods of modifying p53 acetylation and treating cancer using avra |
| 02/16/2012 | US20120039797 Antibody Therapy |
| 02/16/2012 | US20120039796 Novel method for creating, suspending and stabilizing electronically modified oxygen derivatives, along with creating, suspending and stabilizing electronically modified reaction intermediates, in a bio compatible fluorocarbon suspension, for the purpose of inducing a cascading immune response in mammalian patients |
| 02/16/2012 | CA2845198A1 Ggf2 and methods of use |
| 02/16/2012 | CA2843684A1 Compositions, kits and methods for treatment of complement-related disorders |
| 02/16/2012 | CA2808091A1 Stable formulations of linaclotide |
| 02/16/2012 | CA2807946A1 Treatment of penetrative injury to the brain |
| 02/16/2012 | CA2807944A1 Improved hematopoietic stem and progenitor cell therapy |
| 02/16/2012 | CA2807942A1 Erythrocyte-binding therapeutics |
| 02/16/2012 | CA2807685A1 Peptidomimetic macrocycles |
| 02/16/2012 | CA2807206A1 Formulations for infusion of type b lantibiotics |
| 02/16/2012 | CA2807158A1 Treatment of diabetes with pancreatic endocrine precursor cells |
| 02/16/2012 | CA2807136A1 Antisense antiviral compounds and methods for treating a filovirus infection |
| 02/16/2012 | CA2804424A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases |
| 02/16/2012 | CA2804416A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases |
| 02/15/2012 | EP2418281A2 Methods and compositions for delivering polynucleotides |
| 02/15/2012 | EP2418274A2 Multimeric Oxidoreductases |
| 02/15/2012 | EP2418219A1 Methods and agents for the treatment of cancer |
| 02/15/2012 | EP2418218A1 Neuregulin-Beta isoforms associated with neuronal processes |
| 02/15/2012 | EP2418213A1 Neuromedin u derivative |
| 02/15/2012 | EP2417986A1 Bioactive compositions |
| 02/15/2012 | EP2417982A1 Stabilization of gonadotropins |
| 02/15/2012 | EP2417981A1 Peptide PTTKTYFPHF and its uses |
| 02/15/2012 | EP2417980A1 Hybrid polypeptides with selectable properties |
| 02/15/2012 | EP2417974A1 Combination therapy for treatment of immune disorders |
| 02/15/2012 | EP2417968A1 Particle comprising cytokines, antibodies and polymers and use thereof as medicament for the treatment of cancer |
| 02/15/2012 | EP2417259A1 Neuron generation, regeneration and protection |
| 02/15/2012 | EP2417155A1 Targeted delivery of factor viii proteins to platelets |
| 02/15/2012 | EP2417151A1 Cyclic peptides with an anti-parasitic activity |
| 02/15/2012 | EP2417134A1 Macrocyclic serine protease inhibitors |
| 02/15/2012 | EP2416801A1 Immunogenic composition and uses thereof |
| 02/15/2012 | EP2416800A1 Oral lactoferrin in the treatment of severe sepsis |
| 02/15/2012 | EP2416799A2 Par-1 activation by metalloproteinase-1 (mmp-1) |
| 02/15/2012 | EP2416797A2 Amylin agonist compounds for estrogen-deficient mammals |
| 02/15/2012 | EP2416796A1 Modified dnase compositions and methods of use thereof |
| 02/15/2012 | EP2416792A2 Novel anti-aging agents and methods to identify them |
| 02/15/2012 | EP2416785A1 Method of treating and preventing neuro-olfactory triggered or aggravated illnesses or related conditions |
| 02/15/2012 | EP2416763A2 Methods and materials for delivering molecules |
| 02/15/2012 | EP1765861B1 Fgfr binding peptides |
| 02/15/2012 | EP1675869B1 Stabilised compositions |
| 02/15/2012 | EP1661907B1 Method of preparing cardio myopeptidin |
| 02/15/2012 | EP1644019B1 Abuse resistant amphetamine compounds |
| 02/15/2012 | EP1572227B1 Pik4cb involved in the regulation of energy homeostasis |
| 02/15/2012 | EP1532446B1 G-protein coupled receptor ligands and methods |
| 02/15/2012 | EP1381432B1 HSA-free formulations of interferon-beta |
| 02/15/2012 | EP1309705B1 Multivalent target binding protein |
| 02/15/2012 | EP1196430B1 Purification and stabilization of peptide and protein pharmaceutical agents |
| 02/15/2012 | CN102356156A Vector(s) containing an inducible gene encoding a cdk4/cdk6 inhibitor useful for treating neurodegenerative disorders or diseases associated with an unscheduled activation of the cell cycle |
| 02/15/2012 | CN102355909A Combination therapy of an afucosylated antibody and one or more of the cytokines selected from human gm-csf, human m-csf and/or human il-3 |
| 02/15/2012 | CN102355906A Method for preventing and treating hyperpermeability |
| 02/15/2012 | CN102355905A Stroke-generated angiogenesis enhancers and uses thereof |
| 02/15/2012 | CN102355904A Endothelium mimicking nanomatrix |
| 02/15/2012 | CN102352363A Scylla paramamosain antiviral type lipopolysaccharide resistant factor as well as preparation method and application thereof |
| 02/15/2012 | CN102351952A Low-saccharification mutant interferon lambda1 as well as expression and purification methods and application thereof |
| 02/15/2012 | CN102351951A Purification method, extract and preparation of cobra venom neurotoxin |
| 02/15/2012 | CN102351948A Antithrombotic medicine RWR for specifically identifying platelet alpha<IIb>beta3 |
| 02/15/2012 | CN102351946A Healing promoting polypeptide |
| 02/15/2012 | CN102349997A Diagnosis and prevention of cancer cell invasion |
| 02/15/2012 | CN102349996A Human papilloma virus pharmaceutical composition and application thereof |
| 02/15/2012 | CN102349995A Broad-spectrum antiviral medicament as well as preparation method and application thereof |
| 02/15/2012 | CN102349914A Pharmaceutical compositions containing 3, 4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 02/15/2012 | CN102349882A Medicinal composition containing trandolapril and preparation process thereof |
| 02/15/2012 | CN102085217B 含有药用钙盐的早期预防大肠腺瘤或者大肠癌的药物组合物 Early pharmaceutical compositions comprising a pharmaceutically acceptable calcium salt of prevention of colorectal adenomas or colorectal cancer |
| 02/15/2012 | CN102048761B 一种水蛭为原料的肠溶片的制备方法 A process for producing raw materials for the leech enteric-coated tablets |
| 02/15/2012 | CN101843894B 南瓜蛋白在制备治疗肺癌药物中的应用 Pumpkin protein in the manufacture of a medicament for the treatment of lung cancer |
| 02/15/2012 | CN101732698B 一种具有降血糖功效的中药制剂及其制备方法与应用 Chinese medicine and its preparation method and application having a hypoglycemic effect of |
| 02/15/2012 | CN101691580B 人HMGB1 A box和酸性尾端的新型融合蛋白及其应用 Novel fusion protein of human HMGB1 A box and its applications and acidic tail end |
| 02/15/2012 | CN101636414B 聚乙二醇修饰的干扰素α2b及其制备方法和应用 Pegylated interferon α2b and its preparation method and application |
| 02/15/2012 | CN101633699B 一种含抗体模拟物的新型抗生素及其制备方法与应用 New antibiotics and its preparation method and application containing antibody mimetics |
| 02/15/2012 | CN101516402B 凝胶状经肠营养剂 Gel-type enteral nutrient |
| 02/15/2012 | CN101460620B 免疫刺激寡核苷酸及其药物用途 Immunostimulatory oligonucleotides and pharmaceutical use |
| 02/15/2012 | CN101448519B 胸腺素α1在免疫疾病治疗中的用途 Thymosin α1 in use in the treatment of autoimmune diseases |
| 02/15/2012 | CN101172099B 稳定等渗的冻干蛋白质制剂 Stable lyophilized protein formulations isotonic |
| 02/14/2012 | US8114981 Method and medicament for inhibiting the expression of a given gene |
| 02/14/2012 | US8114972 Tumor and infectious disease therapeutic compositions |
| 02/14/2012 | US8114965 Compositions of PSMA antibodies |
| 02/14/2012 | US8114962 Method of detection of nucleic acids with a specific sequence composition |
| 02/14/2012 | US8114960 Heterologous expression of Neisserial proteins |
| 02/14/2012 | US8114959 Stabilized pharmaceutical peptide compositions |
| 02/14/2012 | US8114958 Therapy for metabolism disorders; obesity; diabetes; cardovascular disordrs; eating disorders; hypoglycemic agents; hypotensive agents; dyslipidemia; sleep disorders; respiraotry system disorders; osteoarthritis; insulin resistance |
| 02/14/2012 | US8114913 Systemic administration of NAC as an adjunct in the treatment of bioterror exposures such as smallpox and use in combination with DHEA for the treatment of smallpox |
| 02/14/2012 | US8114909 Treating or preventing restless legs syndrome using prodrugs of GABA analogs |
| 02/14/2012 | US8114896 Method and composition for potentiating an opiate analgesic |
| 02/14/2012 | US8114851 Double stranded RNA packaged in liposome for use therapeutic tool in treatment of cell proliferative and viral disorders; Antisense oligonucleotide for use in prevention and treatment of viral and tumor disorders; gene expression inhibition; RNA interference |
| 02/14/2012 | US8114849 Retinal dystrophy-associated protein and uses thereof |
| 02/14/2012 | US8114848 Immunomodulatory oligonucleotides |
| 02/14/2012 | US8114846 Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors |
| 02/14/2012 | US8114845 Compositions of PD-1 antagonists and methods of use |
| 02/14/2012 | US8114844 Linear and cyclic melanocortin receptor-specific peptidomimetics |
| 02/14/2012 | US8114843 Photoreactive regulator of protein function and methods of use thereof |
| 02/14/2012 | US8114842 Nanoparticles for drug delivery |
| 02/14/2012 | US8114841 Maxillofacial bone augmentation using rhPDGF-BB and a biocompatible matrix |
| 02/14/2012 | US8114840 Medicament containing activated antithrombin III |
| 02/14/2012 | US8114839 Protease resistant modified erythropoietin polypeptides |